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Abstract 
The aims of the study is to assess and compare serum levels of cytokines (IL-8,IL-6,IL-1β,IFN-γ and TNF-α) and 
salivary markers (sIgA, peroxidase, peroxidase specific activity and total protein) in aggressive periodontitis 
patients and periodontally healthy individuals in Mosul. This study was carried out on a total number of 49 
subjects, 24 Aggressive Periodontitis patients,14 males and 10 females, aging between 20 - ≥40 years, and 25 
healthy subjects as control group which consisted of 14 males and 11 females aging between 20-45 years. All 
patients were systemically healthy. Five ml of venous blood and saliva were withdrawn from each patient and 
control subject, for assessments of serum cytokines (IL-8,IL-6,IL-1β,IFN-γ and TNF-α ) and salivary markers 
(sIgA, total protein and peroxidase specific activity) using  ELISA and biochemical test. The comparison of 
serum cytokines and salivary markers between study and control groups showed significance increase in serum 
IL-6 and TNF-α level in Aggressive Periodontitis group. Males showed increase in IL-8, IL-6, IFN-γ, TNF-α 
level, peroxidase and peroxidase specific activity comparing with females, but there increase was not significant. 
Within Aggressive Periodontitis group, serum IL-1β and salivary sIgA showed significance differences according 
to age specially in ≥ 40 year age group. There was unclear correlation between serum cytokines and salivary 
parameters according to the increase of periodontal pocket depth.  
------------------------------------------------------------------------ 
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This study also showed direct correlation between serum IL-1β and Salivary peroxidase, also between (IgA, total 
protein and peroxidase Specific activity in saliva). Finally we found a direct correlation between peroxidase 
specific activity and total protein. 
Keywords: Aggressive Periodontitis; Serum and Salivary Markers. 
1. Introduction 
Aggressive Periodontitis (AP), as the name implies, is a destructive type of periodontitis characterized by severe 
periodontal attachment loss and rapid destruction of alveolar bone around the teeth in conjunction with formation 
of periodontal pockets. AP affects systemically healthy individuals aged <30years but older patients may be 
affected, The global prevalence of AP is much lower than chronic periodontitis and seems to range from 1 % to 
15% of population [1,2]. Some types of AP seems to be inherited in a Mendelian manner [3,4,5], with racial and 
sex tendency, thus adolescence black males have  higher risk for the disease than adolescence whites females, 
although there is variation  between ethnic groups and populations [6]. AP consists of two forms “localised 
aggressive periodontitis” (LAP) and “generalized aggressive periodontitis” (GAP) [7], replaces the older term 
“localized juvenile periodontitis”. In general the prevalence of LAP is nearly 1% and that of GAP is 0.13%. 
However  in Asia the prevalence rate of 1.2% for LAP and 0.6% for GAP in Baghdad and Iran population, 
whereas 0.47% in Japanese population [8]. Besides infection with specific microorganisms [4,9], a host tendency 
seems to play a key role in the pathogenesis of AP as evidenced by present of phagocyte abnormalities, 
hyperresponsive of monocyte / macrophage and elevated cytokines level [2,10,11]. Bacteria and their products 
accumulate in the gingival sulcus and mediate connective tissue destruction whereas stimulating synthesis of 
proinflammatory cytokines (IL) such as interleukins IL-1b, IL-6, IL-8, and tumor necrosis factors (TNF-a), which 
are synthesized by many stimulated cells [12,13]. Numerous studies have suggested that the proportion of 
proinflammatory cytokines could influence the course and development of periodontitis [13,14]. 
2. Materials and Methods 
2.1. Subject Groups 
This study was carried out on total number of 49 subjects , 24 AP patients were selected from patients referred to 
the periodontic clinic in Oral Surgery / College of Dentistry/Mosul University, Iraq and some of private clinics in 
Mosul. Participated patients were to 14 males and 10 females, aging between 20 - ≥40 years, and 25 healthy 
subjects as control group consisted of 14 males and 11 females aging between 20-45 years. In this study  all 
patients were systemically healthy and had not undergone periodontal treatment in the previous 6 months. 
Smokers, alcoholisms, menstruation or pregnancy were excluded from this study. Medical history data were 
determined by chart review and patient interview. The diagnosis for AP status was established for all patients 
according to the 1999 International Classification of Periodontal Diseases and Conditions. Patients were based on 
full mouth periodontal probing and analysis of the alveolar bone level on the perapical and  interproximal 
radiographs [15]. 
2.2. Serum collecting  
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Five ml of venous blood was withdrawn from each patient and control subjects . Blood samples were left to clot 
in a plain tube at 37˚C for 30 minutes, centrifuged at 3000 rpm for 5 minutes, and serum was separated for 
laboratory assessments. A 0.5 ml Eeppendorf tubes were used for preserving serum samples at -20˚C for 
subsequent specific laboratory investigations of serum using of IL-8,IL-6,IL-1β,IFN-γ and TNF-α [16]. 
serum cytokines levels were detected  with ELISA technique:  
1. Human Interleukin-1β ELISA kit, ABO Switzerland Co., Ltd.  
2. Human Interleukin-6 ELISA kit, ABO Switzerland Co., Ltd.  
3. Human Interleukin-8 ELISA kit, Immune Leader.  
4. Human interferon-γ ELISA kit, ABO Switzerland Co., Ltd.  
5. Human Tumor Necrosis Factor-α ELISA kit, ABO Switzerland Co., Ltd.  
2.3. Saliva Collecting 
Non-stimulated saliva was collected from AP and control groups . Subjects were instructed not to brush their 
teeth, or eat or drink 2 hour before the time of saliva collection . Unstimulated whole saliva was collected 
between 10:00 a.m. and 11:00 a.m. Subjects rinsed with water, and saliva samples were collected via passive 
drooling into a sterilized disposable collector cup, Saliva was separated at 3000 rpm for 10 min. The clear 
supernatant fraction was dispensed in a 0.5 ml Eppendorff tubes and stored at -20˚C until biochemical analysis 
[17]. 
Salivary markers used: 
1. Salivary sIgA ELISA kit, Dia Metra.  
2. Saliva total protein biochemical test kit, BIOLABO S.A.  
3. Salivary peroxidase test. 
Protocols for preparing the kits and placing serum and saliva samples were implemented according to the 
instructions of the manufacturer. 
2.4. Statistical analysis 
T-Test, Pearson Chi-Square Test, Post Hoc Test, ANOVA Test, Duncan Test, Correlations, Means, Means plots, 
was used to analyze data. 
3. Results 
The present study was carried out on 49 subject, 24 AP patients 14(58.3%) males, 10(41.7 %) females and 25 
control subjects (14 males, 11females ). (Figure 1)  
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Figure (1): study groups distributed according to gender 
In this study the mean value of serum cytokines levels in AP group were IL-8 (33.846 pg/ml), IL-6(17.433 ng/L), 
IL-1β(36.571 pg/ml), IFN-γ (305.23 ng/L), TNF-α(310.124 ng/L), whereas in control group were IL-8 (31.026 
pg/ml), IL-6 (13.471 ng/L), IL-1β (28.689 pg/ml), IFN-γ (287.30 ng/L), TNF-α (279.94 ng/L). Furthermore 
salivary markers levels in AP group showed sIgA(76.95 µg/ml), Peroxidase (0.174 U/ml), total protein(4.074 
mg/ml), peroxidase specific activity(0.0674 U/mg). whereas control group showed sIgA(90.71µg/ml), peroxidase 
(0.0038 U/ml), total protein(2.701 mg/ml), peroxidase specific activity(0.001 U/mg) levels. In the study group the 
distribution of patients according to age showed presence of 12(50%), 6(25%), 6(25%) of patients in 20-29, 30-
39, ≥40 years, age group respectively (Figure  2). 
 
Figure (2): Shown distribution patients g according to age groups 
The comparison of serum cytokines (IL-8,IL-6,IL-1β,IFN-γ,TNF-α) and salivary markers (sIgA, peroxidase, total 
protein, peroxidase specific activity) levels between AP and control group showed significance increase in serum 
IL-6 and TNF-α level in AP comparing with control group (Figure 3). 
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Figure (3): the comparison of serum and salivary markers levels, between 
patients and control group 
Male patients showed increase in  IL-8, IL-6, IFN-γ, TNF-α levels and peroxidase, peroxidase specific activity 
comparing with females, but its increase was not significant (Figure 4). 
 
Figure (4): the comparison of serum and salivary markers levels, within  aggressive periodontitis patients, 
according to gender 
According to three age groups, AP group showed significance differences in serum IL-1β and salivary sIgA,  
particularly  at ≥ 40 year age group (Figure 5). 
In this study the increase in some serum cytokines and salivary markers were seem as increase of periodontal 
pocket depth specially at 4,5,6 mm pocket depth. On the other hand, serum IL-8, TNF-α and salivary total protein 
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showed decrease in their levels at 7mm pocket depth. However all these differences were not significant. (Figure 
6). 
 
Figure (5): the comparison of serum and salivary markers levels within aggressive periodontitis  patients 
according to three age groups 
 
Figure (6): the comparison of serum and salivary parameter levels within aggressive periodontitis  patients group 
according to periodontal pocket depth 
Results in Table (1) showed presence of direct correlation between serum IL-1β and salivary peroxidase. Also 
presence of direct correlation between salivary IgA with saliva total protein and saliva peroxidase specific 
activity. Finally presence of direct correlation between Salivary peroxidase specific activity and saliva total 
protein. 
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Table 1: Co-relations between serum and Salivary markers within aggressive periodontitis  patients group 
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4. Discussion 
In the study group, high percentage of patients with AP 12(50%) were in age between 20-29 years, (absence of 
adolescent patients  in this study may be related to clinic system ). Whereas another 12(50%) of patients were 
separated to 6(25%) patients to each group 30-39 and ≥40 years. This results is compatible with others [1,18], 
who showed that AP affected at age of ˂ 30 years, but older and younger patients also may be affected [3,4]. 
According to gender this study showed that AP males were more than females but there were no significant 
differences. The males to females percentage concerning AP was 58.3/41.7. Although menstruation and 
pregnancy females were excluded from this study, these criteria may shift female patient’s total percentage. This 
finding is acceptable since many studies showed that the prevalence of AP was nearly equally distributed in 
males and in females [8,18], although females attend dental clinic more than males, asking seek beauty care [19]. 
The comparison between serum cytokines (IL-8,IL-6,IL-1β,IFN-γ,TNF-α) and salivary (sIgA, Peroxidase, total 
protein, peroxidase specific activity) levels in AP and control groups, showed the mean value of IL-6  in AP  
group was (17.43 ng/L) , which was significantly higher than the control group (13.47 ng/L), (P<0.05). while the 
mean value of TNF-α in the AP group was (310.124 ng/L) which was higher than in the control group 
(279.94ng/L) with significant difference (p<0.05), although other parameters showed increase in their levels, but 
there was no significant differences. In the AP group, the mean value of serum TNF-α was significantly increased 
compared with healthy individuals, furthermore, serum TNF-α level was significantly decreased in its 
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concentrations at 6 months post-therapy, but its level remained higher than healthy subjects [18,20,21]. Recent 
study mentioned a positive correlation between the periodontal disease and high serum levels of TNF-α and  
suggesting the use of  TNF-α level as a marker for AP [22]. In contrast treatment with TNF-α inhibitors therapy 
has improved periodontal inflammatory condition [20,23,24]. IL-6 and TNF-α are a pro-inflammatory cytokines 
(inflammation key) that have important regulators of the immune response associated with periodontal disease. In 
the AP group, the mean values of IL-6 was significantly increased compared with control group [25,26,27]. IL-6 
is an important parameter in periodontal research because it plays a crucial role in proliferation and  
differentiation  of B cells into plasma cells. Furthermore IL-6 contributes in bone resorption [28]. IL-6 is present 
at higher level in inflamed tissue, GCF and plasma. Furthermore treatment with IL-6 receptor inhibition therapy 
has improved periodontal inflammatory condition [20,23,25]. Noh and his colleagues suggested that tissue IL-6 
and TNF-α may be related with pathophysiology of periodontitis, and the estimate of these cytokine levels may 
be advantageous to detect of patients with periodontitis [29]. The comparison of serum cytokines (IL-1β,IL-8, 
IFN-γ) and salivary (sIgA, peroxidase, total protein, peroxidase specific activity) levels between AP and control 
groups showed no significant increase in AP comparing with control group. Interleukins 8 is a CXC chemokine 
and the most potent chemo attractant of neutrophils (first line of host defense)  migrates  into the inflamed region 
through the bloodstream [30,31]. In the current study, serum interleukins-8 in patients with AP was not 
significantly different from that of the healthy subjects. This result is compatible with others [32]. Interleukin-1, 
is a pro-inflammatory cytokine has several functions associated  with microbial immune response and active 
stimulators of osteoclastic activity in periodontom. Higher production of IL-1 has been associated with enhanced 
localized response to infection [33]. In the current study serum IL-1β level was not significantly elevation in AP 
compared in healthy subjects, while is compatible with Stefanovska and his colleagues result who found  low 
levels of IL-1 in AP patient’s serum [34]. Furthermore Armitage found an elevation in level of IL-1β in AP 
patient’s tissue which is due to macrophages hyper responsive [2]. In contrasts de Lima Oliveira and his 
colleagues found significant reductions in GCF IL-1β after therapy, and suggested that periodontal therapy 
improved GCF cytokine profiles by lowering IL-1β [35]. Gurban & Drugarin showed elevated level of IFN-γ in 
AP at different stages of disease [36].Whereas Mattuella, et, al., suggested, no significant difference in the 
concentration of  plasma cytokine IFN-γ between AP and healthy group [37]. These results are strongly 
compatible with our findings. In the  present study, the mean values of salivary peroxidase  and peroxidase 
specific activity in AP group were (0.0675) U/mg ,(0.1746) U/ml, which was higher than in healthy group 
(0.0153) U/mg, (0.0383) U/ml with no significant difference (P>0.05). Study finding was  achieved by Taha & 
Al-Taei [18] and  Mirza  &  Al-Azzawi  [38] showed that peroxidase activity had a wide distribution in AP 
inflammation gingiva tissue, specifically in the subepithelial connective tissue, while epithelial tissue showed  
low activity. Moreover Gomes, et, al., found significant increase in myloperoxidase (MPO) level, suggesting use 
it as an inflammatory marker in aggressive periodontitis [39]. In contrast Saxén, et, al., noted decrease in salivary 
peroxidase and MPO in juvenile periodontitis group suggesting that this suppression could be characteristics of 
aggressive periodontitis [40]. In this study AP group showed decrease in salivary IgA levels (76.958) µg/ml, 
compared with healthy subjects (90.701) µg/ml, with no significant differences. Daniel, noted that low salivary 
IgA levels found in students repeatedly colonized by Actinobacillus actinomycetemcomitans which is the most 
prevalent bacteria in aggressive periodontitis [41]. In contrast Al-Rassam & Taha showed a significant increase in 
salivary sIgA level within chronic periodontitis comparing with healthy individuals [42]. The results of the 
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current study showed higher levels of salivary total protein in AP patients (4.0748) mg/ml compared with healthy 
individuals (2.701) mg/ml which was not statistically significant. This result is in agreement with other studies 
[43,44]. Recent study showed statistically significant an increase in concentration of salivary total protein saliva 
in chronic periodontitis patients compared to healthy individuals [17]. The increased protein levels in AP could 
be due to the inflammatory process that activates the sympathetic system to enhance the synthesis and secretion 
of some proteins (as evidenced by increased amylase levels , cathepsin C activity) in the saliva of AP patients, 
thereby increasing the protective potential of saliva against the diseases [43,45]. In contrast Rocha, et, al., showed 
reduced expression of mucin glycoprotein-2 (MG2) and lactoferrin in AP [46]. Furthermore other study 
suggested the increased levels of total protein could partly be also due to an increased leakage of plasma proteins 
into saliva due to inflammation [47]. Thus total protein is a vital component of saliva and is responsible for most 
of its functions like lubrication, physical protection, cleansing, buffering, maintenance of tooth integrity, taste and 
digestion and antibacterial activity [48]. In the present study, male patients showed increase in  IL-8, IL-6, IFN-γ, 
TNF-α level and peroxidase, peroxidase specific activity comparing with female group, but these increases still 
not significance. In contrast Rashmi, et, al., found higher level of TNF-α in periodontitis females GCF compared 
to males but also the mean difference was not statistically significant [20]. Furthermore Al-Rassam & Taha, 
showed no significant differences in serum and salivary parameter in chronic periodontitis patients according to 
gender [42]. According to age groups, AP group showed significance differences in serum IL-1β and salivary 
sIgA, particularly in ≥ 40 year age group. This result may be associated with progressive and severity of AP with 
age.  In this study the increase in some serum cytokines and salivary parameters were related to the increase of 
periodontal pocket depth especially at 4,5,6 mm. From the other hand serum IL-8, TNF-α and salivary total 
protein decreased at 7mm pocket depth, however all these differences are not significant. Yue, et, al., found 
presence of significance correlation between cytokine levels in GCF and saliva with AP clinical parameters, 
furthermore assess of cytokines in saliva may be benefit as a quick method for estimation of periodontal disease 
activity [49]. The present study showed significant correlation between serum IL-1β and saliva peroxides, both 
parameter are associated with infection status. IL-1β is pro-inflammatory cytokines that responsible for immune 
responses regulation. Furthermore salivary peroxidase is a bacterial inhibitor and removes accumulation of H2O2 
that created by oral bacteria. Moreover presence of significance correlation between salivary IgA with saliva total 
protein and salivary peroxidase specific activity. Finally presence of significant correlation between saliva 
peroxides specific activity and saliva total protein. 
5. Conclusion 
Presence of significant increase in serum IL-6 and TNF-α levels in Aggressive Periodontitis patients comparing 
with control group. Aggressive Periodontitis showed significance differences in serum IL-1β and salivary sIgA  
according to age with no clear difference in parameters level according to periodontal pocket depth and gender. 
Presence of direct correlation between serum IL-1β and salivary peroxidase. More studies are required to identify 
the specific role of each cytokine in the initiation and progression of aggressive periodontitis. 
This work is dedicated to the memory of  Dr.Al-Rassam’s wife and his daughter. 
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6. Recommendation 
More studies are required to identify the specific role of each cytokine in the initiation and progression of 
aggressive periodontitis 
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